Semi-quantitative measurement of a specific glycoform using a DNA-tagged antibody and lectin affinity chromatography for glyco-biomarker development

Molecular and Cellular Proteomics

Volumn 14, Issue 3, 2015, Pages 782-795

  Lee, Ju Hee ^a,b   Cho, Chang Hee ^a   Kim, Sun Hee ^a   Kang, Jeong Gu ^a   Yoo, Jong Shin ^c,d   Chang, Chulhun Ludgerus ^e   Ko, Jeong Heon ^a,b   Kim, Yong Sam ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d Chungnam National University   (South Korea)

^e Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; ALPHA FETOPROTEIN; ANTIBODY; ANTIGEN; BIOLOGICAL MARKER; DNA; FUCOSYLTRANSFERASE; GLYCAN; HEMOPEXIN; LECTIN; OLIGONUCLEOTIDE; RNA; GLYCOPROTEIN; TUMOR MARKER;

ADULT; AFFINITY CHROMATOGRAPHY; ANALYTIC METHOD; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; DNA SEQUENCE; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO DIAGNOSTIC MULTIVARIATE INDEX ASSAY; LIVER CELL CARCINOMA; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN GLYCOSYLATION; QUANTITATIVE ANALYSIS; RNA TRANSCRIPTION; SENSITIVITY AND SPECIFICITY; BLOOD; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; DNA MICROARRAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER NEOPLASMS; METABOLISM; MOLECULAR PATHOLOGY; PROCEDURES; TUMOR CELL LINE;

ANTIBODIES; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; DNA; GLYCOPROTEINS; HUMANS; LECTINS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PATHOLOGY, MOLECULAR;

EID: 84924299993     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.O114.043117     Document Type: Article

References (37)

1. Christiansen, M. N., Chik, J., Lee, L., Anugraham, M., Abrahams, J. L., and Packer, N. H. (2014) Cell surface protein glycosylation in cancer. Proteomics 14, 525-546
2. Kim, Y. S., Hwang, S. Y., Kang, H. Y., Sohn, H., Oh, S., Kim, J. Y., Kim, C. H., Jeon, J. H., Lee, J. M., Kang, H. A., Miyoshi, E., Taniguchi, N., Yoo, H. S., and Ko, J. H. (2008) Functional proteomics study reveals that N-acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1. Mol. Cell. Proteomics 7, 1-14
3. Häuselmann, I., and Borsig, L. (2014) Altered tumor-cell glycosylation promotes metastasis. Front. Oncol. 4, 28
4. Meany, D. L., and Chan, D. W. (2011) Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin. Proteomics 8, 7
5. Kim, Y. S., Yoo, H. S., and Ko, J. H. (2009) Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery. Protein Pept. Lett. 16, 499-507
6. Adamczyk, B., Tharmalingam, T., and Rudd, P. M. (2012) Glycans as cancer biomarkers. Biochim. Biophys. Acta 1820, 1347-1353
7. Cheng, J., Wang, W., Zhang, Y., Liu, X., Li, M., Wu, Z., Liu, Z., Lv, Y., and Wang, B. (2014) Prognostic role of pretreatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis. PLOS One 9, e87011
8. Xia, Y., Yan, Z. L., Xi, T., Wang, K., Li, J., Shi, L. H., Wu, M. C., and Shen, F. (2012) A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy. Hepatogastroenterol. 59, 2248-2254
9. Potapovich, A. I., Pastore, S., Kostyuk, V. A., Lulli, D., Mariani, V., De Luca, C., Dudich, E. I., and Korkina, L. G. (2009) alpha-Fetoprotein as a modulator of the pro-inflammatory response of human keratinocytes. Br. J. Pharmacol. 158, 1236-1247
10. Androutsopoulos, G., Gkogkos, P., and Decavalas, G. (2013) Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome. Int. J. Endocrinol. Metab. 11, 102-106
11. Shiraki, K., Takase, K., Tameda, Y., Hamada, M., Kosaka, Y., and Nakano, T. (1995) A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 22, 802-807
12. Duffy, M. J., Evoy, D., and McDermott, E. W. (2010) CA 15-3: uses and limitation as a biomarker for breast cancer. Clin. Chim. Acta 411, 1869-1874
13. Galli, C., Basso, D., and Plebani, M. (2013) CA 19-9: handle with care. Clin. Chem. Lab. Med. 51, 1369-1383
14. Kang, J. G., Ko, J. H., and Kim, Y. S. (2011) Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer. BMB Rep. 44, 765-771
15. Rifai, N., Gillette, M. A., and Carr, S. A. (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24, 971-983
16. Anderson, N. L., and Anderson, N. G. (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867
17. Hong, Q., Lebrilla, C. B., Miyamoto, S., and Ruhaak, L. R. (2013) Absolute quantitation of immunoglobulin G and its glycoforms using multiple reaction monitoring. Anal. Chem. 85, 8585-8593
18. Kos̈cielak, J. (1995) Diseases of aberrant glycosylation. Acta Biochim. Pol. 42, 1-10
19. Zhang, H., Li, X. J., Martin, D. B., and Aebersold, R. (2003) Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling, and mass spectrometry. Nat. Biotechnol. 21, 660-666
20. US Department of Health and Human Services, authors. Draft Guidance for Industry, Clinical Laboratories, and Staff: In Vitro Diagnostic Multivariate Index Assays. [Accessed April 2, 2012]. http://www.fda.gov/downloads/ MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ ucm071455.pdf.
21. Ihara, S., Miyoshi, E., Ko, J. H., Murata, K., Nakahara, S., Honke, K., Dickson, R. B., Lin, C. Y., and Taniguchi, N. (2002) Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J. Biol. Chem. 277, 16960-16967
22. Guo, H. B., Lee, I., Kamar, M., Akiyama, S. K., and Pierce, M. (2002) Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res. 62, 6837-6845
23. Guo, H. B., Lee, I., Kama, M., and Pierce, M. (2003) N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways. J. Biol. Chem. 278, 52412-52424
24. Zhou, H., Briscoe, A. C., Froehlich, J. W., and Lee, R. S. (2012) PNGase F catalyzes de-N-glycosylation in a domestic microwave. Anal. Biochem. 427, 33-35
25. Wilson, D. S., Wu, J., Peluso, P., and Nock, S. (2002) Improved method for pepsinolysis of mouse IgG(1) molecules to F(ab)(2) fragments. J. Immunol. Methods 260, 29-36
26. Chen, S., LaRoche, T., Hamelinck, D., Bergsma, D., Brenner, D., Simeone, D., Brand, R. E., and Haab, B. B. (2007) Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat. Methods 4, 437-444
27. Bruix, J., and Sherman, M.; American Association for the Study of Liver Diseases. (2011) Management of hepatocellular carcinoma: an update. Hepatology 53, 1020-1022
28. Sterling, R. K., Jeffers, L., Gordon, F., Venook, A. P., Reddy, K. R., Satomura, S., Kanke, F., Schwartz, M. E., and Sherman, M. (2009) Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and desgamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin. Gastroenterol. Hepatol. 7, 104-113
29. Shiraki, K., Takase, K., Tameda, Y., Hamada, M., Kosaka, Y., and Nakano, T. (1995) A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 22, 802-807
30. Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., Roberts, L. R., Reddy, K. R., Harnois, D., Llovet, J. M., Normolle, D., Dalhgren, J., Chia, D., Lok, A. S., Wagner, P. D., Srivastava, S., and Schwartz, M. (2009) Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectinbound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 137, 110-118
31. Ueland, F. R., Desimone, C. P., Seamon, L. G., Miller, R. A., Goodrich, S., Podzielinski, I., Sokoll, L., Smith, A., van Nagell, J. R. Jr., and Zhang, Z. (2011) Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors. Obstet. Gynecol. 117, 1289-1297
32. Zhang, Z. (2012) An in vitro diagnostic multivariate index assay (IVDMIA) for ovarian cancer: harvesting the power of multiple biomarkers. Rev. Obstet. Gynecol. 5, 35-41
33. Ransohoff, D. F. (2005) Bias as a threat to the validity of cancer molecularmarker research. Nat. Rev. Cancer 5, 142-149
34. Bellet, D. H., Wands, J. R., Isselbacher, K. J., and Bohuon, C. (1984) Serum alpha-fetoprotein levels in human disease: perspective from a highly specific monoclonal radioimmunoassay. Proc. Natl. Acad. Sci. U.S.A. 81, 3869-3873
35. Delanghe, J. R., and Langlois, M. R. (2001) Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin. Chim. Acta 312, 13-23
36. McMahon, M. J., Bowen, M., Mayer, A. D., and Cooper, E. H. (1984) Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am. J. Surg. 147, 164-170
37. Ransohoff, D. F. (2007) How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design. J. Clin. Epidemiol. 60, 1205-1219